AstraZeneca warns of higher costs as drug sales slide

By Ben Hirschler LONDON (Reuters) - British drugmaker AstraZeneca (LSE:AZN) warned on Thursday of higher costs in 2013 as it invests through a slump in sales caused by a wave of patent expires on key medicines. ...

by via Yahoo! Finance: Top Stories